Physician profile
Leanne K Strack
NPI 1982653432
$3,530.29
in general payments reported to CMS, 2019-2025
21 companies · $872 in 2025
The $872 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.89 · 2020: $179 · 2021: $179 · 2022: $600 · 2023: $764 · 2024: $854 · 2025: $872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,376 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,376.16 |
| Education | $113.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $747.54 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $626.52 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $529.27 | 2022-2025 | |
| Mylan Specialty L.P. | $309.07 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $239.23 | 2023-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $225.61 | 2021-2025 | Opsumit |
| Astellas Pharma US INC | $146.03 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.08 | 2020-2025 | Ofev |
| Mallinckrodt Hospital Products INC. | $129.33 | 2022-2025 | Acthar |
| Sanofi-Aventis U.S. LLC | $79.99 | 2023 | |
| Baxter Healthcare | $67.27 | 2023-2025 | Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $52.96 | 2025 | Arikayce, Brinsupri |
| Merck Sharp & Dohme LLC | $47.09 | 2024 | Keytruda |
| Takeda Pharmaceuticals U.S.A., INC. | $44.10 | 2023-2024 | Glassia |
| Grifols USA, LLC | $30.56 | 2025 | Prolastin-C Liquid |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $23.89 | 2025 | Purified Cortrophin Gel |
| United Therapeutics Corporation | $22.96 | 2019 | |
| Viatris Specialty LLC | $19.33 | 2025 | Yupelri |
| Janssen Biotech, INC. | $18.56 | 2025 | Tremfya |
| Circassia INC. | $16.49 | 2019 | |
| Verona Pharma, INC. | $16.41 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leanne Strack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.